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Based on a combination of SDS-PAGE and mass spectrometry, a protein with an apparent molecular mass of 31 kDa (termed as VP31)
was identified from purified shrimp white spot syndrome virus (WSSV) envelope fraction. The resulting amino acid (aa) sequence matched
an open reading frame (WSV340) of the WSSV genome. This ORF contained 783 nucleotides (nt), encoding 261 aa. A fragment of WSV340
was expressed in Escherichia coli as a glutathione S-transferase (GST) fusion protein with a 6His-tag, and then specific antibody was raised.
Western blot analysis and the immunoelectron microscope method (IEM) confirmed that VP31 was present exclusively in the viral envelope
fraction. The neutralization experiment suggested that VP31 might play an important role in WSSV infectivity.
D 2005 Elsevier Inc. All rights reserved.Keywords: White spot syndrome virus; VP31; Envelope protein; The neutralization experimentIntroduction
White spot syndrome virus (WSSV) is a major shrimp
pathogen that is highly virulent in penaeid shrimp and can
also infect most species of crustacean (Lo et al., 1996a,
1996b; Chen et al., 1997; Flegel, 1997). The complete
sequence of WSSV genome has now been published for
three different isolates (Chen et al., 2002; van Hulten et al.,
2001a; Yang et al., 2001; GenBank Accession Nos.
AF332093, AF369029, AF440570 for viruses isolated from
China, Thailand, and Taiwan, respectively). Recently, the
International Committee on Taxonomy of Viruses approved
a proposal to erect WSSV as the type species of the genus
Whispovirus, family Nimaviridae (www.ncbi.nlm.nih.gov/
ICTVdb/Ictv/index.htm).
To date, some major structural proteins have been
identified (Huang et al., 2002b; Tsai et al., 2004). Among
those proteins, VP28, VP26/P22, VP281, VP466, VP68,0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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proteins by immunoelectron microscopy (Huang et al.,
2002a, 2002b; Zhang et al., 2002a, 2002b, 2004). As far
as functional research is concerned, VP28, VP281,
VP466, and VP68 were suggested to play an important
role in the systemic WSSV infection in shrimp by using
an in vivo neutralization assay (van Hulten et al., 2001b;
Wu et al., 2005), and VP28 was used for detection of
WSSV in crustaceans (Yoganandhan et al., 2004); VP281,
with a cell attachment RGD motif, was supposed to play
an important role in mediating WSSV infectivity (Huang
et al., 2002a); VP26 was reported to be capable of
binding to actin or actin-associated proteins (Xie and
Yang, 2005).
In this paper, the purified WSSV virions, viral envelope
fractions were separated by SDS-PAGE. Among these
proteins, a 31 kDa protein (termed VP31) was analyzed
using Nano-ESI MS/MS and further identified by Western
blot and TEM (transmission electron microscopy) immuno-
gold-labeling. In vivo neutralization assay was performed in
this investigation to examine if VP31 can play a role in
WSSV infection.05) 125 – 132
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Identification of WSSV-VP31 by MS
The proteins of the WSSV virion, the envelope and
nucleocapsid fraction were separated on 12% SDS-PAGE
gel, respectively. As shown in Fig. 1A, the 31 kDa protein
band (arrow indicated) was sequenced using Nano-ESI mass
spectrometry. Ten experimentally derived peptide masses
were found to match the predicted peptide masses of the
VP31 protein, covering 46% the amino acid sequence
(sequence coverage: 120 aa/261 aa = 46%, date not shown).
Sequence alignment identified that the resulting amino acid
sequence matched WSV340 of the WSSV genome ORF
database. WSV340 is located from nucleotide position
196252–195510 on the genome and encodes a protein of
261 amino acids, with a theoretical molecular mass of
29.6 kDa.
Characterization of WSSV vp31 gene
Rapid amplification of cDNA ends (RACE)
The 5V and 3V regions of the vp31 transcript were
obtained by rapid amplification of the cDNA end (RACE).
The RNA samples used in this study were prepared from
the crayfish at 24 h p.i. In 5V RACE, after two rounds of
PCR amplifications, the PCR products formed a singleFig. 1. Coomassie brilliant blue stained 12% SDS-PAGE gel of purified
WSSV virions, WSSV envelope and WSSV nucleocapsids and Western
blot analysis. (A) SDS-PAGE of purified WSSV virions, WSSV envelope
and WSSV nucleocapsids. Intact viral particles were obtained with
differential centrifugations. The virus envelope was removed from the
virus particles by treatment with 0.2% Triton X-100. Then, the purified
WSSV virions, WSSV envelope and WSSV nucleocapsids were assayed
by 12% SDS-PAGE with Coomassie staining. Lanes: M, low-molecular-
weight protein marker. 1, purified WSSV virions. 2, purified WSSV
envelope. 3, purified WSSV nucleocapsids. (B) Western blot analysis. The
viral envelope and nucleocapsid proteins, after separation by SDS-PAGE,
were transferred onto a PVDF membrane followed by incubation with anti-
rVP31c serum (diluted at 1:5000) and alkaline phosphatase-conjugated goat
anti-mouse IgG, respectively. Lane 1, the viral envelope; Lane 2, the viral
nucleocapsids.band in agarose gel at about 280 bp (Fig. 2A). Analysis of
the products (Fig. 2B) revealed that the transcription
initiation site was located at 94 nt upstream of the
predicted ATG initiation codon, a putative TATA box
was found at 37 nt upstream of the transcriptional
initiation sites. Amplification of the 3V region of the first-
strand cDNA in 3V RACE yielded PCR products of about
320 bp (Fig. 2A). Although there was no putative
polyadenylation signal (AATAAA), a possible polyadeny-
lation signal (AATAAT) (Caron et al., 2001; Halder et al.,
1998) was found at 22 nt upstream of a poly (A) tail by
sequencing 3V RACE fragments (Fig. 2B).
Temporal expression of vp31 transcription in WSSV-infected
shrimp
RT-PCR was performed to detect vp31-specific tran-
scripts at different infection stages (0 to 48 h p.i.). The result
showed that this gene transcript was first detected at 12 h
p.i. and continued high transcription until 48 h p.i. (Fig.
3A). This result suggested the vp31 gene was a late gene,
just as most of WSSV late genes (Huang et al., 2002b;
Zhang et al., 2002a, 2002b). For the positive control, the
results of RT-PCR with actin-specific primers were shown
in Fig. 3B. When RNA was treated with RNase and then
subjected to RT-PCR with vp31-specific primers, no RT-
PCR amplicon was seen, indicating that no virus genomic
DNA was left in the prepared RNA (negative control, date
not shown).
Expression of rVP31c in E. coli BL21 (DE3)
The C-terminal fragment of vp31 (vp31c) was cloned
into the pET-GST vector and overexpressed as a GST
fusion protein in BL21 (DE3) strain. A band corre-
sponding to the GST-VP31c fusion protein was observed
in the induced GST-VP31c as the expected size (date
not shown). No protein band was found at the same
position in uninduced GST-VP31c. The expressed fusion
protein was purified by Ni-NTA resin under denaturing
conditions. Purified rVP31c was used for antibody
preparation.
Western blot analysis
Purified WSSV virions, envelope proteins and nucle-
ocapsid proteins were separated by SDS-PAGE, respec-
tively (Fig. 1A). Western blot results showed that the
rVP31c polyclonal antiserum was reacted specifically with
VP31 in the purified viral envelope proteins, while no
binding could be found in the nucleocapsid proteins (Fig.
1B). It confirmed that this protein should belong to viral
envelope.
Localization of VP31 protein by IEM
Purified WSSV virions were tested to be intact under
transmission electron microscopy (Fig. 4A). When both
WSSV virions and nucleocapsids were incubated with
rVP31c antiserum followed with gold-labeled secondary
Fig. 2. Nucleotide sequence of WSSV vp31 containing the 5V and 3V terminal region and the deduced VP31 protein sequence (one-letter code). (A) Agarose gel
analysis of the 5V RACE and 3V RACE products. Lane M, 100 bp ladder DNA marker (Promega). After two rounds of PCR amplifications, the PCR products
formed a single 280-bp band in 5V RACE and 320-bp band in 3V RACE. (B) The nucleotide sequence of the presumptive WSSV vp31 gene and the deduced
VP31 amino acid sequence. The predicted TATA box, the possible polyadenylation signal (AATAAT), the start codons, two N-glycosylation sites (NLSE,
NRTG) and FArg–Gly–Asp_ motif were boxed. Transcription start point and poly (A) were indicated with black dots. Primers used for 5V/3VRACE (VP31sp1,
VP31sp2, VP31sp3) were underlined.
Fig. 3. Temporal transcription analysis of WSSV-vp31 at different post-
infection times (h.p.i.). RT-PCR with the gene-specific primers was
performed using the total RNAs extracted from the infected crayfish. (A)
RT-PCR with WSSV-vp31-specific primers. The transcript was first
detected at 12 h p.i. and continued to be highly transcribed until 48 h
p.i.; (B) RT-PCR with h-actin-specific primers. No RT-PCR amplicon was
observed. Lane M: 100 bp DNA ladder marker. Lane headings showed h
p.i. (0, 2, 4, 6, 8, 12, 18, 24 and 48 h p.i.).
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the surface of the WSSV virions (Fig. 4D), while no
particles could be found on the nucleocapsids (Fig. 4B). In
the control experiments, rVP31c antiserum was replaced
with a pre-immune mouse serum as the primary antibody,
no gold particles could be seen for the WSSV virion too
(Fig. 4C).
Neutralization assay
The results showed that the crayfish mortalities were
very low for the negative control (0.9% NaCl). The crayfish
from the positive control (WSSV only) displayed 100%
mortality at 8 days post-infection, and the crayfish from the
anti-GST IgG control displayed 100% mortality at 9 days
post-infection. Whereas after the mixture of WSSV with
anti-rVP31c IgG was injected into crayfish, the crayfish
mortality was significantly delayed (Fig. 5), indicating that
the infection of WSSV could be delayed or neutralized by
antibodies against rVP31c. Deceased shrimps were con-
Fig. 4. Localization of VP31 in the WSSV virions by immunoelectron
microscopy (IEM) (Scale bar, 90 nm). (A) Electron micrograph of
negatively stained intact WSSV virions (2% PTA); (B) Nucleocapsids of
WSSV incubated with anti-rVP31c antiserum as primary antibody followed
by gold-labeled secondary antibodies. (C) Intact WSSV virions incubated
with pre-immune mouse serum as primary antibody followed by gold-
labeled secondary antibodies. (D) Intact WSSV virions incubated with anti-
rVP31c antiserum as primary antibody followed by gold-labeled secondary
antibodies. Gold particles were indicated by arrows.
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not shown).Discussion
White spot syndrome virus is a major pathogen of
cultured penaeid shrimp worldwide. After the completion of
the WSSV genomic DNA sequencing, research has nowFig. 5. Neutralization of WSSV infection in crayfish by specific antibodies. The so
crayfish were used. After injections, the crayfish mortality was monitored daily
mortality on the ordinate.focused on the functional analysis of the gene products,
especially on the functions of the viral envelope proteins.
Recently, a simple and efficient method for purifying the
virions and separating envelope proteins from virions has
been developed in our laboratory (Xie et al., 2005), which
facilitated the identification of the viral structural proteins
with low abundance. By combining SDS-PAGE with mass
spectrometry, vp31 was predicted to encode an envelope
protein. This protein was also discovered by another study,
in which the VP31 was shown to be a structural protein
without further analysis on protein location and function
(Tsai et al., 2004). In this study, Western blot showed that
VP31 was in the envelope fraction. IEM further revealed
that gold particles were present along the intact WSSV
virions. This provided visual evidence that the vp31 gene
encodes one of the envelope proteins of WSSV.
Computer analysis showed that the predicted vp31 enco-
ding protein lacks a predominant transmembrane domain,
which suggested that VP31 might be a fusion protein that
contained a domain involved in binding to other viral
envelope protein for membrane anchoring. The same instance
has been found at the vaccinia virus membrane protein, the
VV 14-kDa protein that is located on the surface of the
intracellular mature virus form, and is essential for both the
release of extracellular enveloped virus from the cells and
virus spread (Marı´a-Isabel et al., 1998). Such form had also
been widely reported in some viral membrane fusion pro-
teins, pathogen receptors and some cell adhesion molecules
(Boyle and Compton, 1998; Jordens et al., 1999). These pro-
teins could function to anchor the polypeptides to the
membrane hydrophobic phase by means of locating aqueous
activities or possibly interact with some membrane-spanning
components (Stevens and Arkin, 2000). Therefore, we pre-
sume that VP31 protein plays an important role in the biology
of the virus, acting in virus-to-cell and cell-to-cell fusions.
In addition, the cell attachment motif RGD (Ruoslahti
and Pierschbacher, 1986) occurred in vp31 gene sequence
(Fig. 3) suggested that the tripeptide recognition motif mightlutions used for injection were shown at the bottom. For each treatment, 20
at 25 -C. Days post-injection were shown on the abscissa and percentage
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studies, RGD structure has been reported widely to mediate
the virus–host interaction (Senn and Klaus, 1993; Krezel et
al., 1994; Verdaguer et al., 1995; Yingmanee et al., 2001;
Mandl et al., 1989; Ruoslahti, 1996). Among WSSV
proteins, six structure proteins, including VP31, have been
reported to contain RGD motif (Tsai et al., 2004). Moreover,
VP31 possesses a threonine at the fourth position of the
RGD motif (RGDT), which was considered to be critical in
interacting with integrin (Plow et al., 2000).
Antibodies raised against individual viral envelope
protein have been used successfully in neutralization assay
to identify envelope proteins involved in virus entry during
infection (Martignoni et al., 1980; Schofield et al., 2000;
van Hulten et al., 2001a, 2001b; Volkman and Goldsmith,
1985; Wu et al., 2005). In this study, a specific antiserum
against VP31 protein was prepared to test for neutralization
in vivo. The result suggested that VP31 should be involved
in the systemic infection of WSSV in crayfish by partici-
pating in virus attachment and membrane fusion. Future
experiments would be performed to demonstrate which part
of VP31 was involved in the neutralization process and what
the role of VP31 in WSSV attachment and entry in the
systemic infection was.
In summary, we identified a structure protein VP31 as an
envelope protein. VP31 might be a key protein in viral
invasion and could be a good candidate for screening
receptors on shrimp cell surface. Study on VP31 will be
helpful to realize the mechanism of the virus infection and
to control the infection of WSSV in shrimp industry.Materials and methods
Virus purification and detergent extraction of intact virus
The WSSV isolate in this study originated from Penaeus
japonicus (Xiamen, China) and was proliferated in an
alternate host, the crayfish (Procambarus clarkii). Prepara-
tion of WSSV virions and nucleocapsids was carried out as
described previously (Xie et al., 2005). Brief, abundant viral
particles were obtained with only a few steps of conven-
tional differential centrifugations, the upper loose pellet was
rinsed out, and purified virus in white pellet were
resuspended and kept in TM buffer (50 mM Tris–HCl, 10
mM MgCl2, pH 7.5).
The virus envelope was removed from the virus
particles by treatment with Triton X-100. Generally, the
purified WSSV was mixed with an equal volume of 0.2%
Triton X-100 and incubated for 1 h at room temperature.
The nucleocapsids were purified by centrifugation at
20,000  g for 20 min at 4 -C. The envelope fraction
was collected in the supernatant. The nucleocapsid fraction
was subjected to a second round of Triton X-100
extraction to ensure the envelopes were removed com-
pletely. The degree of purity of the intact virions isolatedand nucleocapsid fractions were evaluated by negative-
staining transmission electron microscopy.
Mass spectrometric analysis of VP31
The intact virions, envelope fractions and nucleocapsid
fractions were obtained as above. Purified WSSV virions
and the viral envelope fractions were separated using 12%
SDS-PAGE (Laemmli, 1970) and stained with Coomassie
brilliant blue R-250. A 31 kDa target protein band was
excised from the gel and dehydrated several times with
acetonitrile. After vacuum drying, the gel band was
incubated with 10 mM dithiothreitol in 100 mM ammonium
bicarbonate (ABC buffer) at 57 -C for 60 min and
subsequently with 55 mM iodoacetamide (Sigma) in 100
mM ABC buffer at room temperature for 60 min. Then, the
gel was washed with 100 mM ABC buffer and dried. In-gel
protein digestion was performed using sequencing grade
modified porcine trypsin (Promega, Madison, WI) in 50
mM ABC buffer at 37 -C for 15 h. Digests were centrifuged
at 6000  g. The supernatants were separated, and the gel
pieces were extracted further first with 50% acetonitrile, 5%
formic acid and then with acetonitrile. The extracts were
combined with the original digesting supernatants, vacuum-
dried and redissolved in 0.5% trifluoroacetic acid and 50%
acetonitrile (Shevchenko et al., 1996). Subsequently, in-gel-
digested sample was sequenced using Nano-ESI MS/MS
mass spectrometry as described previously (Huang et al.,
2002b). The resulting mass spectrometric data were
searched against the theoretical ORF database of WSSV.
Computer analysis of the vp31
The potential sites for posttranslational modifications
were analyzed by the PROSITE database (Hofmann et al.,
1999); The prediction of transmembrane domain and hydro-
phobic region of WSSV-VP31 was performed with TM-pred
program (Hofman and Stoffel, 1993) and DNAMAN
software (Lynnon BioSoft, Vaudreuil, Canada), respectively.
Characterization of WSSV vp31 gene
Rapid amplification of vp31 cDNA ends (5V and 3V RACE)
Based on the nucleotide sequence of ORF340, the 5V and
3V ends of the cDNA encoding WSSV-VP31 were obtained
by 5V and 3V RACE using a commercial 5V/3V RACE kit
(Roche), according to the manufacturer’s recommendations.
The RNA samples used in this study were extracted from
WSSV-infected crayfish 24 h p.i. and then treated with
RNase-free DNase. For 5VRACE, the first-strand cDNAwas
synthesized using the specific primer sp1 (5V-GGCCGA-
TACCAATGTACAAG-3V), and then a poly (A) tail was
added to the cDNA products using terminal transferase in
the presence of dATP. The primer sp2 (5V-CTTA-
CAGTGTTCTTCAAC-3V) and an oligo (dT) anchor primer
supplied with the kit were used for PCR. For 3VRACE, first-
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primer. The primer sp3 (5V-GAGGATGTAGATGCAGTG-
3V) and an anchor primer supplied with the kit were used for
PCR. The PCR products from 5V and 3V RACE were each
purified on a 2% agarose gel and subcloned into the
pMD18-T vector (TaKaRa). Arbitrarily selected clones were
sequenced and compared with the genomic DNA sequence
of WSSV.
Transcriptional analyses of genes
The WSSV inoculum collected from virus-infected
shrimp P. japonicus was inoculated into the crayfish
according to the protocol described before (Li et al.,
2004). Total RNAs at different times (i.e. 0, 2, 4, 6, 8, 12,
18, 24 and 48 h post infection, h p.i.) were extracted from
the hepatopancreas of WSSV-infected crayfish according to
the single-step RNA isolation method (Chomczynski and
Sacchi, 1987). The obtained RNAwas further purified using
the SV Total RNA Isolation System (Promega) and
quantified by spectrophotometry at 260 nm. The total
RNA (2 Ag) was reverse transcribed with M-MLV RT [H-]
(Promega) using gene-specific reverse primer (GGCCGA-
TACCAATGTACA). The cDNAs were subjected to PCR
using specific forward primer (5V-ATGAAGGATGCA-
GAACTG-3V) and reverse primer (GGCCGATACCAATG-
TACA). The PCR cycles were as follows: 94 -C for 2 min,
30 cycles of 94 -C for 30 s, 55 -C for 30 s, 72 -C for 1 min
followed by an elongation at 72 -C for 10 min. The
crayfish h-actin gene was used as the internal control for
RT-PCR with a gene specific primer set (5V-TCAT-
CAGGGTGTGATGGT-3V and 5V-TCTGAGTCATCTTCT-
CAC-3V). Total RNA from healthy crayfish was used as the
negative control.
Partial expression of GST-VP31 fusion protein in
Escherichia coli
The WSSV-vp31 gene C-terminal fragment (termed as
vp31c) was amplified from WSSV genomic DNA using the
forward primer (5V-CGGGATCC CAAGAAACTGGT-
CAAGT-3V) and the reverse primer (5V-CGGAATTC
CTCCTCCTTAAAAGCAG-3V) that contained recognition
sequences for BamHI and EcoRI restriction enzymes
(underlined). The amplicon was cloned into the pET-GST
vector (Gene Power Lab Ltd Shenzhen office). The
recombinant plasmid was transformed into E. coli BL21
(DE3) cells. Liquid cultures were grown in a shaking
incubator (200 rpm) at 37 -C until the OD600 reached 0.7,
and these were then induced with 0.2 mM IPTG for 5 h at
37 -C. The cells were harvested by centrifugation at
4000  g for 5 min. The recombinant VP31c (termed
rVP31c) was purified by Ni-NTA affinity chromatography
under denatured conditions following methodology in the
QIAexpressionist handbook (Qiagen). The E. coli cells
containing pET-GST vector were also induced with IPTG,
and total protein extracts were applied to the Ni-NTAcolumn as described above. Final eluates were collected and
used as the negative control.
Preparation of antibody
Purified rVP31c protein was used as antigen to immunize
mice by intradermal injection once every 10 days. Antigen
(30 Ag) was mixed with an equal volume of Freund’s
complete adjuvant (Sigma) for the first injection. Subse-
quent three injections were conducted using 30 Ag antigen
mixed with an equal volume of Freund’s incomplete
adjuvant (Sigma). Four days after the last injection, mice
were exsanguinated, and antisera were collected. The titers
of the antisera were 1:15,000, as determined by ELISA. The
IgG fraction was purified with rProtein A–Sepharose Fast
Flow (Amersham). The optimal dilution of purified IgG,
after serial dilutions, was 1:5000 as determined by ELISA.
Horseradish-peroxidase (HRP)-conjugated goat anti-mouse
IgG was obtained from Promega. For a negative control,
antigen was replaced with 1 PBS.
Western blot
Virus envelope fraction and nucleocapsid fraction dis-
solved in loading buffer were separated by SDS-PAGE
(Laemmli, 1970), respectively. These proteins were trans-
ferred onto a PVDF membrane (Amersham Pharmacia). The
membrane was then immersed in blocking buffer (2% BSA,
20 mM Tris, 150 mM NaCl, 0.1% Tween 20, pH 7.5) at
room temperature for 30 min followed by incubation with
anti-rVP31c serum (diluted 1:5000) for 1 h. Following this,
alkaline-phosphatase-conjugated goat anti-mouse IgG
(Promega) was used as the secondary antibody. Detection
was performed using Western Blue Stabilized Substrate for
Alkaline Phosphatase (Promega).
Localization of VP31 protein by immunoelectron
microscopy
WSSV virion and nucleocapsid suspension were mounted
on carbon-coated nickel grids (300 meshes) for 1 h at room
temperature. Respectively, after washing with PBS, the grids
were blocked in 3% BSA for 1 h. Then, the grids were rinsed
with PBS followed by incubation with anti-rVP31c IgG as
the primary antibody (1:200, diluted in 3% BSA) for 2 h.
After washing four times with 1 PBS, 10-nm-gold-labeled
anti-mouse goat IgG as the secondary antibody (Sigma) was
added to the grids and incubated for 1 h at room temperature.
Grids were washed further four times with 1 PBS and
stained with 2% phosphotungstic acid (PTA, pH 7.0) for 25
min. Specimens were examined under a TEM. For control
experiment, anti-rVP31c IgG was replaced with a pre-
immune mouse serum as the primary antibodies indicated
above.
Neutralization assay
Prior to injection into crayfish, WSSV virions were
incubated with anti-rVP31c IgG or the anti-GST IgG as a
L. Li et al. / Virology 340 (2005) 125–132 131control (final concentration 4 Ag IgG/ml, 107 virions/ml) for
1 h at room temperature. Then, the 100 Al mixture of
antibody and WSSV was intramuscularly injected into
crayfish using a syringe with 29-gauge needle. At the same
time, a negative (0.9% NaCl) and a positive control (virus
only, 107 virions/ml) were included in the injections. For
each treatment, 20 crayfish were used. After injections, the
crayfish mortality was monitored daily at 25 -C. Deceased
shrimps were examined for the presence of WSSV by PCR
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